$Adalimumab in the treatment of refractory adult‐onset Still's disease$

Adalimumab in the treatment of refractory adult‐onset Still's disease

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of rheumatic diseases 2017-11, Vol.20 (11), p.1798-1799
Hauptverfasser:	Lee, Won‐Seok, Yoo, Sun‐Ho, Ko, Ryoung‐Eun, Yoo, Wan‐Hee
Format:	Artikel
Sprache:	eng
Schlagworte:	Adalimumab - therapeutic use Aged Anti-Inflammatory Agents - therapeutic use Humans Immunotherapy Juvenile rheumatoid arthritis Male Monoclonal antibodies Remission Induction Still's Disease, Adult-Onset - diagnosis Still's Disease, Adult-Onset - drug therapy Still's Disease, Adult-Onset - immunology TNF inhibitors Treatment Outcome Tumor Necrosis Factor-alpha - antagonists & inhibitors Tumor Necrosis Factor-alpha - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!